Metcalfe Named Interim CEO of GreenFuel

Ethernet inventor Bob Metcalfe has been named interim CEO of Cambridge clean energy company GreenFuel Technologies, Xconomy has learned. He replaces highly touted energy industry veteran Cary Bullock, who was hired in March 2005 to head the company, which develops algae bioreactor systems that convert carbon dioxide emissions into renewable, clean-burning biofuels. Details of Metcalfe’s … Continue reading “Metcalfe Named Interim CEO of GreenFuel”

EdNets, Inc. Secures $2,969,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53be68ec-a7b8-4f8a-85e4-cf56e8d63c8a&Preview=1 Date 6/30/2007 Company Name EdNets, Inc. Mailing Address 107 Audubon Road, Building Two 109, MA 01880 Company Description The company’s mission is to improve education through web technology and increasing school funding. Website http://www.ednets.com Transaction Type Venture Equity Transaction Amount $2,969,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “EdNets, Inc. Secures $2,969,000 New Financing Round”

OraMetrix Secures $5,208,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e4910f80-9b3f-4fa9-8b41-ec03361f283c&Preview=1 Date 6/30/2007 Company Name OraMetrix Mailing Address 2350 Campbell Creek Blvd. Richardson, TX 75082 Company Description Our proprietary technology system, the SureSmile system, represents a significant leap forward in orthodontics because it allows the use of precision digital tools throughout all phases of the orthodontic treatment process – diagnosis, treatment planning … Continue reading “OraMetrix Secures $5,208,000 New Funding”

Genzyme Takeover Deal Will Fail, Predicts Bioenvision Shareholder

Genzyme’s tender offer for New York-based Bioenvision, which expires at 12:01 Monday morning, will not be approved, predicts a large Bioenvision shareholder opposed to the deal. “We’ve heard it’s fallen flat as hell,” asserts Jeffrey Davis, president of SCO Capital, a New York asset-management group focused on life sciences. SCO Capital owns roughly 13 percent … Continue reading “Genzyme Takeover Deal Will Fail, Predicts Bioenvision Shareholder”

Aveo’s Better Mousetraps for Cancer Drugs

Oncology researchers are fond of saying that if you’re a mouse with cancer, they’ve found drugs that can cure you. Scientists at Cambridge-based Aveo Pharmaceuticals have even better news: They’ve developed mice with tumors that don’t always respond well to anticancer drugs. That heralds an important advance because it means that cancers in Aveo’s bioengineered … Continue reading “Aveo’s Better Mousetraps for Cancer Drugs”

CombinatoRx Pulls the Plug on Arthritis Drug

Kendall Square-based CombinatoRx announced today that it is discontinuing development of CRx-150 after the drug candidate targeting rheumatoid arthritis performed poorly in a Phase 2 clinical trial. A combination of the antidepressant amoxapine and the cardiovascular drug dipyridamole, CRx-150 did offer some pain-control benefit compared to placebo, the company said, but failed to meet clinical … Continue reading “CombinatoRx Pulls the Plug on Arthritis Drug”

Startup Profile: Xconomy Part 2

You meet a lot of people and do a lot of talking when you’re setting out to launch a company. In the course of creating Xconomy, between seeking investors and raising underwriting funds, I took an estimated 17 trips to the Bay Colony Corporate Center in Waltham, home to what’s probably the greatest concentration of … Continue reading “Startup Profile: Xconomy Part 2”

Brooks Steps Down as CSAIL Head, Dives Back into Science

Quipping that he is experiencing “a scientific mid-life crisis,” legendary robotics pioneer Rod Brooks is stepping down as Director of MIT’s Computer Science and Artificial Intelligence Laboratory. Brooks’ reign at CSAIL, which he has directed since its 2003 formation, will formally end on Friday. However, today marks his first day in his new office, where … Continue reading “Brooks Steps Down as CSAIL Head, Dives Back into Science”

Startup Profile: Xconomy

No sooner had Verizon connected our telephone lines than the phones began ringing off the hook. We dropped our Ikea wrenches to field calls from investors, attorneys, and underwriters. Then came the telemarketing blitz from insurance peddlers, payroll services, financing companies. There was even one slightly peeved call from a big law firm trying to … Continue reading “Startup Profile: Xconomy”

Cyber-Rain, Inc. Secures New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba2a2b1f-943a-478f-a189-5f0a6a871ed9&Preview=1 Date 6/25/2007 Company Name Cyber-Rain, Inc. Mailing Address 5272 Evanwood Ave Oak Park, CA 91377 Company Description The Cyber-Rain XCI controller is designed for homeowners who want to save time, money and natural resources with an easy-to-use system that they can easily install and run themselves. Website http://www.cyber-rain.com Transaction Type Venture … Continue reading “Cyber-Rain, Inc. Secures New Funding Round”

Nuance Communications Acquires Tegic Communications Inc. for $265,000,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5c84a0c9-fe33-4429-a8bd-941d4d6aa456&Preview=1 Date 6/21/2007 Company Name Tegic Communications Inc. Mailing Address 1000 Dexter Avenue N. Seattle, WA 98109 Company Description Tegic Communications builds robust, innovative, embedded software designed to enhance communications on small mobile devices. Website http://www.tegic.com Transaction Type M&A Transaction Amount $265,000,000 Transaction Round Proceeds Purposes M&A Terms Under the terms of … Continue reading “Nuance Communications Acquires Tegic Communications Inc. for $265,000,000”

Newcomer Alert: Brian Moon Arrives from the U.K. to Tap Local Talent

Product-design and technology-consulting firm Cambridge Consultants (the other Cambridge) announced late last week that it was moving its U.S. headquarters and its previously U.K.-based CEO, Brian Moon, to Kendall Square. The company’s U.S. staff, which was until now based in Boston’s Fort Point Channel, is set to quadruple in size in three to five years. … Continue reading “Newcomer Alert: Brian Moon Arrives from the U.K. to Tap Local Talent”

Color Kinetics Stock Soars, Yellow Flag Raised

It’s been a good year for Boston-based digital-lighting leader Color Kinetics, whose stock surged Thursday to an all-time high after the company announced a big licensing deal that will make its LED technology even more visible at events and performances. But shares dipped Friday when a leading analyst downgraded the company from “Buy” to “Hold.” … Continue reading “Color Kinetics Stock Soars, Yellow Flag Raised”

Pop!Tech 2007

This annual event in a quaint Maine seaside town brings together visionaries in science, technology, the social sciences, culture, the arts, and more. This year’s theme is “The Human Impact,” exploring how individuals can have an effect on other people and on the world.

Mixed Feelings on State Funding for Stem Cells

A month after Gov. Deval Patrick announced a planned billion-dollar funding initiative to bolster stem cell research in Massachusetts, the local research community is still awaiting details. But a representative of the governor’s office stopped by a symposium today at the law firm of Nixon Peabody today to give some hints. Jon Mahoney, industry director … Continue reading “Mixed Feelings on State Funding for Stem Cells”

Newcomer Alert: Patrice Milos Joins Struggling Helicos

Following on the heels of last month’s disappointing IPO, Helicos BioSciences is making a new addition to its executive suite: Pfizer veteran Patrice Milos. Milos, most recently the executive director of Pfizer Global Research and Development, will serve as Helicos’s VP and CSO. Alan Louie, research director at Health Industry Insights, says the hire is … Continue reading “Newcomer Alert: Patrice Milos Joins Struggling Helicos”

A Deal Too True to be Good? Shareholder Uprising Aims to Disrupt Genzyme’s Takeover Plans

It was just business—good business. Or so it seemed last week, when Genzyme announced its $350 million acquisition of New York-based Bioenvision. In fact, it seemed like a good deal for both parties. Under the terms of the arrangement, Genzyme (GENZ) agreed to acquire Bioenvison (BIVN) for $5.60 a share. That marked a 50% premium … Continue reading “A Deal Too True to be Good? Shareholder Uprising Aims to Disrupt Genzyme’s Takeover Plans”

Shopping 3.0: The New Face of e-Commerce

I fully realized that the third generation of shopping was upon us when Sharon Jester Turney, CEO of Limited Brands Direct, turned to me and said something along the lines of how she needed something to add the sex to the new Victoria’s Secret website. That one utterance, delivered without irony, wove together several threads … Continue reading “Shopping 3.0: The New Face of e-Commerce”

Dreamerz Foods Secures $10,000,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24444800-0b8e-4fc2-877a-7dac5355e281&Preview=1 Date 6/5/2007 Company Name Dreamerz Foods Mailing Address 535 Pacific Avenue 3rd Floor San Francisco, CA 94133 Company Description We were inspired to create a safe, effective all-natural product that not only helped us sleep, but also tasted delicious and satisfied our craving for a healthy indulgence before bedtime. We painstakingly … Continue reading “Dreamerz Foods Secures $10,000,000 Series B Funding”

Legends of Kendall Square: Doc Edgerton

With all that happens so quickly in life, Dr. Harold “Doc” Edgerton made his name by bringing the fastest-moving things on earth to a dead halt. His teams developed the technology to literally stop a bullet in front of your eyes, synchronizing flash photography with the exact moment of impact, the moment of truth—when the … Continue reading “Legends of Kendall Square: Doc Edgerton”

Ultreo, Inc. Secures $5,500,000 Series C Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22282074-adb8-4e93-b1b9-0b7eb8ca633f&Preview=1 Date 5/25/2007 Company Name Ultreo, Inc. Mailing Address 9461 Willows Road NE Redmond, WA 98052 Company Description Ultreo combines ultrasound waveguide technology and precisely tuned sonic bristle action for an incredibly gentle, deep, long-lasting feeling of clean. Ultreo’s combined technologies can remove hard-to-reach plaque bacteria that bristle action alone can leave … Continue reading “Ultreo, Inc. Secures $5,500,000 Series C Round”

Arete Therapeutics Secures $13,300,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=786e6307-b077-4efe-bbbd-197236e29966&Preview=1 Date 5/23/2007 Company Name Arete Therapeutics Mailing Address 7000 Shoreline Court South San Francisco, CA 94080 Company Description Arête Therapeutics Inc. is discovering and developing ‘first in class’ small molecule drugs directed at novel targets for cardiovascular diseases and inflammation. The Company’s proprietary therapies are directed at a new branch of … Continue reading “Arete Therapeutics Secures $13,300,000 Series A Financing”

Nuance Communications Acquires VoiceSignal Technologies, Inc. for $293,000,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=77d33ebf-c5e2-4c71-bccf-674707efb620&Preview=1 Date 5/15/2007 Company Name VoiceSignal Technologies, Inc. Mailing Address 150 Presidential Way Woburn, MA 01801 Company Description VoiceSignal’s VSuite, VSpeak, VoiceMode and VSearch solutions are designed to address the ease-of-use problem that increasingly confronts users of today’s mobile devices. Website http://www.voicesignal.com Transaction Type M&A Transaction Amount $293,000,000 Transaction Round Proceeds Purposes … Continue reading “Nuance Communications Acquires VoiceSignal Technologies, Inc. for $293,000,000”

AOL LLC Acquires Third Screen Media for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5136c7f5-8af1-4d20-b8c0-67ed25d72528&Preview=1 Date 5/15/2007 Company Name Third Screen Media Mailing Address 88 Black Falcon Ave. Boston, MA 02210 Company Description Third Screen Media (TSM) enables advertising on mobile phones and wireless devices. Website http://www.thirdscreenmedia.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms Financial terms of the transaction were not … Continue reading “AOL LLC Acquires Third Screen Media for Undisclosed Sum”

DepotPoint Lands $4,000,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f5bc973b-8724-4ccc-a0a1-a39e1f132bf7&Preview=1 Date 5/8/2007 Company Name DepotPoint Mailing Address 1406 140th Place NE Bellevue, WA 98007 Company Description DepotPoint’s vision is to be the leading provider of technologies that optimize the tracking, recording, and management of property related data. The company utilizes its centralized workflow and tracking technology to create solutions for participants … Continue reading “DepotPoint Lands $4,000,000 Series B Round”

Combinent BioMedical Systems, Inc. Receives Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7567bcf-2bf6-47d3-a1bc-3783ad0ff57f&Preview=1 Date 5/7/2007 Company Name Combinent BioMedical Systems, Inc. Mailing Address 420 Bedford Street Lexington, MA 02420 Company Description Combinent BioMedical Systems, Inc. is an emerging specialty pharmaceutical company that is developing novel drug combinations and formulations of existing pharmaceutical products using its proprietary transvaginal drug delivery system (TVDS). Combinent has targeted … Continue reading “Combinent BioMedical Systems, Inc. Receives Series A Round”

NetSocket Secures $12,800,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51eb2e79-5e97-4cb3-ada4-19898ae84105&Preview=1 Date 4/30/2007 Company Name NetSocket Mailing Address 3701 W. Plano Pkwy. Plano, TX 75075 Company Description NetSocket has created the world’s first real-time IP service assurance solution: the patented, award-winning, and innovative Session2Topology correlation engine. NetSocket empowers network operators to correlate previously disparate information about both network state and real-time IP … Continue reading “NetSocket Secures $12,800,000 Series A Funding”

Ellacoya Networks Inc. Lands $13,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1d8bd507-16cb-492a-b7fc-afc7ccaafbcd&Preview=1 Date 4/26/2007 Company Name Ellacoya Networks Inc. Mailing Address 7 Henry Clay Drive Merrimack, NH 03054 Company Description Ellacoya Networks is an innovative technology company building breakthrough service control platforms for broadband service provider markets. Website http://www.ellacoyanetworks.com Transaction Type Venture Equity Transaction Amount $13,000,000 Transaction Round Undisclosed Proceeds Purposes It will … Continue reading “Ellacoya Networks Inc. Lands $13,000,000 New Funding Round”

VoloMedia Garners $8,500,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5936c772-3901-41af-bb88-d7ba7d5cccf7&Preview=1 Date 4/20/2007 Company Name VoloMedia Mailing Address 800 W. California Ave. Sunnyvale, CA 94086 Company Description VoloMedia provides advertising, metric, and reporting solutions that help publishers unlock the value of their downloadable audio and video assets while enabling advertisers to accurately target high-value emerging markets. Website http://www.volomedia.com Transaction Type Venture Equity … Continue reading “VoloMedia Garners $8,500,000 Series B Round”

Spine Wave Inc. Secures $45,000,000 Series D Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c4bab83c-c92c-4f50-be10-534654414651&Preview=1 Date 4/10/2007 Company Name Spine Wave Inc. Mailing Address Two Enterprise Drive Shelton, CT 06484 Company Description Spine Wave is a medical device company focused on the development and marketing of clinical solutions for three of the largest and fastest growing spinal market segments: nuclear replacement and augmentation, vertebral compression fracture … Continue reading “Spine Wave Inc. Secures $45,000,000 Series D Round”

Zafgen, Inc. Secures $400,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=85678dc8-efb8-4310-9a9c-3573097a59c4&Preview=1 Date 3/31/2007 Company Name Zafgen, Inc. Mailing Address 29 Newbury Street Boston, MA 02116 Company Description The company is developing novel therapeutics for the treatment of obesity. Website http://www.zafgen.com Transaction Type Venture Equity Transaction Amount $400,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Atlas … Continue reading “Zafgen, Inc. Secures $400,000 New Financing Round”

Nexaweb Technologies Garners $2,000,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eb92a983-8470-4e70-863f-f012ee0eb763&Preview=1 Date 3/31/2007 Company Name Nexaweb Technologies Mailing Address One Van de Graaff Drive Burlington, MA 01803 Company Description Nexaweb provides the leading software platform for building and deploying Enterprise Internet Applications. Website http://www.nexaweb.com/ Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A … Continue reading “Nexaweb Technologies Garners $2,000,000 New Financing”

IlluminOss Medical, Inc. Receives $2,600,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=58269d7a-148a-406b-b1f4-d19a24dbfdc0&Preview=1 Date 3/30/2007 Company Name IlluminOss Medical, Inc. Mailing Address 993 Waterman Avenue East Providence, RI 02914 Company Description The company is a medical device startup developing technologies for orthopedic surgery applications. Website http://www.illuminossmedical.com Transaction Type Venture Equity Transaction Amount $2,600,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “IlluminOss Medical, Inc. Receives $2,600,000 Series A Financing”

ChemoCentryx Receives $29,840,000 Series D Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62d0cfc4-5fbe-47d3-9762-9f9a5966d3b3&Preview=1 Date 3/22/2007 Company Name ChemoCentryx Mailing Address 850 Maude Avenue Mountain View, CA 94043 Company Description ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. Website http://www.chemocentryx.com Transaction … Continue reading “ChemoCentryx Receives $29,840,000 Series D Funding Round”

Pulse Entertainment Garners $5,800,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d4b86dd-f891-4d20-95db-19305bfc7a2b&Preview=1 Date 3/21/2007 Company Name Pulse Entertainment Mailing Address 620 Folsom St. San Francisco, CA 94107 Company Description Pulse Mobile is a leading provider of multimedia messaging and user-generated content creation technologies for mobile and web applications. Our patent-protected Veepers™ Content Engine (VCE) platform is also a powerful personalization engine for user-generated … Continue reading “Pulse Entertainment Garners $5,800,000 New Round”